19 July 2019

• 03:11 03:11, 19 July 2019 diff hist +3‎ m 2019 in Japan ‎No edit summary Tag: Visual edit
• 03:10 03:10, 19 July 2019 diff hist +2‎ 2019 in Japan ‎ Improved flow of the sentences, grammar etc. Tag: Visual edit

17 January 2019

• 22:34 22:34, 17 January 2019 diff hist −15‎ Bronze ‎ Removed unnecessary opinion from statue picture. Tag: Visual edit

26 October 2018

• 00:31 00:31, 26 October 2018 diff hist +1‎ m Titusville, Florida ‎ Added a D to locate

4 May 2018

• 20:37 20:37, 4 May 2018 diff hist −3‎ Cerro Armazones ‎ Edit for better sentence flow. Tag: Visual edit

14 February 2018

• 15:37 15:37, 14 February 2018 diff hist +1,045‎ Malacidin ‎ Added chembox to begin adding details about this molecule. Tag: Visual edit: Switched

12 February 2018

• 15:26 15:26, 12 February 2018 diff hist +89‎ Sarin ‎ Changed micro gram from ug to μg Tag: Visual edit

3 November 2017

• 20:16 20:16, 3 November 2017 diff hist +166‎ User talk:Ahwchemistry ‎ →‎class assignment?

1 November 2017

• 21:46 21:46, 1 November 2017 diff hist +1,029‎ Dupilumab ‎ Added pharmacokinetic data, moved mechanism to pharamacodynamics section. Added detailed information on Phase III SOLO trials and Phase II asthma trials. Tag: Visual edit

31 October 2017

• 21:59 21:59, 31 October 2017 diff hist +2‎ m Etelcalcetide ‎ →‎Mechanism of action Tag: Visual edit
• 21:59 21:59, 31 October 2017 diff hist +1,171‎ Etelcalcetide ‎ Reorganized information, added clinical trial information. Added Commercialization information regarding ownership in Japan. Added pharmacokinetics information. Tag: Visual edit
• 14:45 14:45, 31 October 2017 diff hist +3‎ m Etelcalcetide ‎ →‎History: Moved to a more chronological order. Tag: Visual edit
• 02:16 02:16, 31 October 2017 diff hist +1,850‎ Dupilumab ‎ Moved Clinical Studies to Development as Requested. Added Secondary source for CHRONOS and other trials. Tag: Visual edit
• 01:46 01:46, 31 October 2017 diff hist +16‎ Etelcalcetide ‎ →‎Clinical Trials: Updated information of clinical trials. Tag: Visual edit

30 October 2017

• 23:55 23:55, 30 October 2017 diff hist +501‎ Etelcalcetide ‎No edit summary Tag: Visual edit
• 23:24 23:24, 30 October 2017 diff hist +387‎ Talk:Dupilumab ‎No edit summary
• 19:31 19:31, 30 October 2017 diff hist +305‎ Talk:Dupilumab ‎ →‎Proposed Patent Information Section
• 18:42 18:42, 30 October 2017 diff hist −2‎ m Etelcalcetide ‎ →‎Clinical Trials Tag: Visual edit
• 18:29 18:29, 30 October 2017 diff hist −6‎ m Etelcalcetide ‎ →‎Development: Reformatted AMGEN Tag: Visual edit
• 18:27 18:27, 30 October 2017 diff hist +10‎ m Etelcalcetide ‎ Link to AMGEN added. Tag: Visual edit
• 18:27 18:27, 30 October 2017 diff hist +194‎ m Etelcalcetide ‎ Edited information on drug ownership. Tag: Visual edit
• 18:26 18:26, 30 October 2017 diff hist +2,962‎ Etelcalcetide ‎ Added information on development by KAI. Added patents currently in process for drug. Added Clinical Trial Information from FDA. Tag: Visual edit
• 15:18 15:18, 30 October 2017 diff hist +497‎ Dupilumab ‎ →‎Clinical trials: Re-Added CHRONOS data using better link. This citation was also included in the NEJM article also used as a reference on this page. Tag: Visual edit
• 15:15 15:15, 30 October 2017 diff hist +255‎ Dupilumab ‎ Undid revision 807424016 by Doc James ( talk)
• 15:13 15:13, 30 October 2017 diff hist +305‎ Talk:Dupilumab ‎ →‎Proposed Patent Information Section: new section
• 14:52 14:52, 30 October 2017 diff hist +227‎ N User:Ahwchemistry ‎ ←Created page with 'Hello there! My name is Alex, I am currently pursuing my Ph.D. in Pharmaceutical Sciences at the University of Kentucky. Of any pages I may edit. I am not affi...' current

27 October 2017

• 18:57 18:57, 27 October 2017 diff hist +773‎ Dupilumab ‎ →‎Clinical trials: - Added CHRONOS Phase III trial. Tag: Visual edit

25 October 2017

• 20:32 20:32, 25 October 2017 diff hist +356‎ Dupilumab ‎ →‎Development: Added confirmation of cGMP by the FDA Tag: Visual edit
• 19:16 19:16, 25 October 2017 diff hist +1,359‎ Dupilumab ‎ Google Patents is a tertiary source, they consolidate information regarding the patent approval process. The original patent would be the primary source. Tag: Visual edit: Switched
• 19:12 19:12, 25 October 2017 diff hist +146‎ Dupilumab ‎ Added information regarding Regeneron profits. Tag: Visual edit

20 October 2017

• 20:39 20:39, 20 October 2017 diff hist +1,346‎ Dupilumab ‎ Patent information regarding Dupilumab from Regeneron. Tag: Visual edit
• 19:08 19:08, 20 October 2017 diff hist +15‎ m Dupilumab ‎ Added SEC filing date for 10-Q information. Tag: Visual edit
• 19:04 19:04, 20 October 2017 diff hist +513‎ Dupilumab ‎ Added development information between Sanofi and Regeneron. Added description of drug as a receptor antagonist for further reading. Tag: Visual edit

19 October 2017

• 23:25 23:25, 19 October 2017 diff hist +1,268‎ Dupilumab ‎ Added independent side effect heading. Added information about clinical trial. Replaced press releases from Regeneron with scientific journals showing stated results. Tag: Visual edit